All practice questions

4736 questions

Question 441Question →

Match each patient's clinical presentation with the most appropriate targeted laboratory test to confirm the underlying etiology or assess disease-specific risk.

Click a left item, then click its matching right item

Items

A 35-year-old woman with a history of recurrent late-term pregnancy losses presenting with a prolonged activated partial thromboplastin time that fails to correct with a normal plasma mixing study.
A 52-year-old man presenting with chronic, destructive sinusitis, cavitary pulmonary lesions on chest imaging, and acute kidney injury with red blood cell casts.
A 45-year-old woman with rapidly progressive skin thickening over her trunk and proximal extremities presenting with acute oliguric renal failure and a blood pressure of 210/118 mmHg.
A 62-year-old woman evaluated for an acute onset of proximal muscle weakness and a violaceous periorbital rash, who was recently found to have a malignant ovarian mass.

Matches

Show answer & explanation

Answer

Match the prolonged uncorrectable aPTT with dRVVT; the destructive sinusitis and glomerulonephritis with PR3-ANCA; the scleroderma renal crisis with Anti-RNA polymerase III; and the paraneoplastic dermatomyositis with Anti-TIF1-γ.
Each clinical vignette represents a specific autoimmune or rheumatologic syndrome that requires a highly targeted laboratory test for definitive diagnosis or risk stratification. Dilute Russell viper venom time (dRVVT) confirms lupus anticoagulant in antiphospholipid syndrome. PR3-ANCA is highly sensitive and specific for granulomatosis with polyangiitis. Anti-RNA polymerase III is a major risk factor for scleroderma renal crisis in systemic sclerosis. Anti-TIF1-γ is a specific marker for paraneoplastic dermatomyositis.

Step-by-Step Solution

1
Analyze the first presentation (recurrent fetal loss, uncorrectable aPTT).
Identify suspected Antiphospholipid Syndrome (APS) secondary to lupus anticoagulant.
Mixing study failure indicates an inhibitor. Recurrent miscarriages paired with this lab anomaly are classic for APS, which is confirmed using a dilute Russell viper venom time (dRVVT) assay.
2
Analyze the second presentation (destructive sinusitis, cavitary lung lesions, nephritic syndrome).
Identify suspected granulomatosis with polyangiitis (GPA).
This specific multi-organ involvement (upper airway, lower airway, and kidneys) requires PR3-ANCA testing for diagnostic confirmation.
3
Analyze the third presentation (rapid skin thickening, malignant hypertension, acute kidney injury).
Identify scleroderma renal crisis (SRC).
SRC is a life-threatening complication of diffuse cutaneous systemic sclerosis. Anti-RNA polymerase III strongly correlates with rapidly progressive skin disease and high risk of SRC.
4
Analyze the fourth presentation (proximal weakness, heliotrope rash, ovarian mass).
Identify paraneoplastic dermatomyositis.
Dermatomyositis presenting in an older adult with a solid organ mass strongly suggests a paraneoplastic etiology, which is specifically associated with Anti-TIF1-γ antibodies.

Key Concept

Targeted autoantibody and specific laboratory test ordering for rheumatologic and systemic autoimmune diseases based on distinct clinical phenotypes.
Question 442Question →

A 28-year-old man of Mediterranean descent is admitted to the oncology unit for initiation of induction chemotherapy. He was recently diagnosed with a highly aggressive B-cell non-Hodgkin lymphoma characterized by a t(8;14)t(8;14) chromosomal translocation. Baseline laboratory studies show a serum uric acid level of 11.5 mg/dL11.5 \text{ mg/dL}, lactate dehydrogenase of 1,250 U/L1,250 \text{ U/L}, and a serum creatinine of 1.1 mg/dL1.1 \text{ mg/dL}. To mitigate the risk of an impending oncologic emergency, the patient is administered a recombinant enzyme therapy that directly degrades uric acid into a highly soluble inactive metabolite. Forty-eight hours later, the patient develops sudden-onset fatigue, scleral icterus, and dark urine. His hemoglobin concentration has decreased from 14.2 g/dL14.2 \text{ g/dL} to 8.4 g/dL8.4 \text{ g/dL}. A peripheral blood smear reveals the presence of bite cells. The medication that precipitated this patient's acute deterioration is absolutely contraindicated in individuals who have a primary hereditary inability to synthesize adequate amounts of which of the following molecules?

Show answer & explanation

Answer: Nicotinamide adenine dinucleotide phosphate

Answer

Nicotinamide adenine dinucleotide phosphate
The correct answer is nicotinamide adenine dinucleotide phosphate (NADPH). The patient was administered rasburicase (recombinant urate oxidase) to manage impending tumor lysis syndrome from his high-grade Burkitt lymphoma. Rasburicase catalyzes the oxidation of uric acid to the highly soluble allantoin, but this reaction concurrently produces hydrogen peroxide (H2O2H_2O_2). In erythrocytes, H2O2H_2O_2 is detoxified to water by glutathione peroxidase, a reaction that requires the oxidation of reduced glutathione. To maintain a steady supply of reduced glutathione, glutathione reductase must utilize NADPH. NADPH is generated exclusively via the pentose phosphate pathway by the enzyme glucose-6-phosphate dehydrogenase (G6PD). Patients with G6PD deficiency (common in those of Mediterranean or African descent) cannot synthesize adequate amounts of NADPH during times of high oxidative stress. Consequently, administering rasburicase to these patients leads to massive accumulation of H2O2H_2O_2, denaturation of hemoglobin (forming Heinz bodies, which macrophages bite out to form bite cells), and acute hemolytic anemia. Therefore, rasburicase is absolutely contraindicated in G6PD deficiency, a condition defined by the primary hereditary inability to synthesize adequate NADPH.

Step-by-Step Solution

1
Identify the primary oncologic diagnosis and its associated risk.
The patient has Burkitt lymphoma (t(8;14)t(8;14)) with highly elevated LDH and uric acid, indicating a high tumor burden and impending tumor lysis syndrome (TLS).
Recognizing the risk of TLS dictates the necessary prophylactic management sequence.
2
Identify the specific pharmacologic intervention administered.
The patient received rasburicase, a recombinant urate oxidase that degrades uric acid to allantoin.
The stem describes a recombinant enzyme that directly degrades uric acid, which distinguishes it from allopurinol (which prevents synthesis).
3
Determine the pathophysiologic mechanism of the patient's acute deterioration.
Rasburicase produces hydrogen peroxide (H2O2H_2O_2) as a byproduct. The patient developed acute oxidative hemolytic anemia (jaundice, dark urine, dropping hemoglobin, bite cells) from this oxidative stress.
Connecting the drug's biochemical mechanism of action to the adverse clinical presentation is required to identify the underlying contraindication.
4
Identify the underlying hereditary defect and its primary biochemical product.
The patient has glucose-6-phosphate dehydrogenase (G6PD) deficiency, an absolute contraindication to rasburicase. G6PD normally synthesizes nicotinamide adenine dinucleotide phosphate (NADPH).
NADPH is essential for regenerating reduced glutathione, which detoxifies H2O2H_2O_2 in erythrocytes. Without NADPH, hemolysis occurs.

Key Concept

Rasburicase, utilized for tumor lysis syndrome, produces hydrogen peroxide and is strictly contraindicated in patients with G6PD deficiency due to their inability to synthesize adequate NADPH for erythrocyte oxidative defense.
Estimated Time:1m 30s
Question 443Question →

A 45-year-old man comes to the clinic for a routine follow-up examination of type 2 diabetes mellitus. His current regimen includes metformin and a newly added oral antihyperglycemic medication, which was started four weeks ago. The patient reports that his home fasting blood glucose readings have improved significantly. However, he has noticed that his shoes feel tighter and he has gained 2.5 kg (5.5 lb) since his last visit. He has a history of mild heart failure with preserved ejection fraction. Physical examination reveals 2+ bilateral pitting edema of the lower extremities. Laboratory studies show a fasting plasma glucose of 112 mg/dL. The physician realizes the new medication is responsible for the patient's fluid retention, which is exacerbating his underlying cardiac condition, and plans to discontinue it immediately. The discontinued drug most likely exerts its primary therapeutic effect by initially binding to which of the following cellular targets?

Show answer & explanation

Answer: Intracellular receptor that heterodimerizes with the retinoid X receptor

Answer

The correct target is an intracellular receptor that heterodimerizes with the retinoid X receptor, which correctly describes the mechanism of action of thiazolidinediones.
The clinical presentation of improved glycemic control accompanied by new-onset weight gain and peripheral edema in a patient with a history of heart failure strongly points to the recent initiation of a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone. TZDs are agonists of the peroxisome proliferator-activated receptor gamma (PPAR-gamma). PPAR-gamma is an intracellular (nuclear) receptor. Upon binding a TZD, PPAR-gamma forms a heterodimer with the retinoid X receptor (RXR). This complex binds to specific DNA response elements to alter the transcription of various genes, ultimately increasing adiponectin levels, promoting adipocyte differentiation, and increasing insulin sensitivity (e.g., via GLUT4 upregulation). A major side effect of TZDs is fluid retention due to increased sodium reabsorption in the renal collecting ducts via upregulation of epithelial sodium channels (ENaC). This fluid retention can precipitate or exacerbate heart failure, making TZDs strictly contraindicated in these patients.

Step-by-Step Solution

1
Analyze the patient's new symptoms following the initiation of an oral antidiabetic drug.
The patient developed significant weight gain and bilateral pitting edema of the lower extremities.
Identifying the specific side effect profile is essential to determining the drug class responsible.
2
Correlate the side effects and the patient's medical history with antidiabetic medication classes.
Thiazolidinediones (e.g., pioglitazone) are known to cause fluid retention and weight gain, and they carry a black box warning for causing or exacerbating heart failure.
This confirms the newly added medication was a thiazolidinedione, explaining the physician's immediate decision to discontinue it.
3
Identify the cellular mechanism of action for thiazolidinediones.
They bind to peroxisome proliferator-activated receptor gamma (PPAR-gamma), an intracellular nuclear receptor.
The question specifically asks for the cellular target of the discontinued medication.
4
Determine the downstream molecular pathway of PPAR-gamma activation.
Upon binding its ligand, PPAR-gamma heterodimerizes with the retinoid X receptor (RXR) to alter the transcription of insulin-responsive genes.
This matches the correct option describing the receptor's specific behavior.

Key Concept

Thiazolidinediones (TZDs) improve insulin sensitivity by binding to PPAR-gamma, an intracellular nuclear receptor that heterodimerizes with the retinoid X receptor (RXR) to regulate the transcription of genes involved in glucose and lipid metabolism. Due to their tendency to increase renal sodium reabsorption leading to fluid retention, TZDs are contraindicated in patients with symptomatic heart failure.
Question 444Question →

A 62-year-old woman is brought to the emergency department by her daughter due to severe shortness of breath and wheezing that began 24 hours ago. The patient has a history of mild intermittent asthma but has not required an albuterol inhaler in over a decade. Her past medical history is also notable for essential hypertension, hyperlipidemia, and a newly diagnosed ocular condition characterized by elevated intraocular pressure, for which she saw an ophthalmologist three weeks ago. She is a lifelong nonsmoker. Her current oral medications include amlodipine and atorvastatin. When asked about other medications, she initially states she takes nothing else, but upon targeted questioning regarding her recent ophthalmology visit, she confirms she started a new twice-daily eye drop three weeks ago. Temperature is 37.0°C (98.6°F), blood pressure is 122/76 mmHg, pulse is 52/min, and respirations are 24/min. Oxygen saturation is 91% on room air. Physical examination reveals diffuse bilateral wheezing with a prolonged expiratory phase. The skin is warm and dry, and the oral mucosa is moist. There is no excessive lacrimation, salivation, or abnormal bowel sounds. A detailed medical history reveals that the systemic absorption of her new eye medication is likely responsible for her current presentation. Which of the following is the primary mechanism of action of the most likely responsible medication?

Show answer & explanation

Answer: Antagonism of beta-adrenergic receptors

Answer

The correct answer is antagonism of beta-adrenergic receptors.
The correct answer identifies antagonism of beta-adrenergic receptors. The patient has classical signs of systemic non-selective beta-blockade: acute bronchospasm (beta-2 receptor blockade) and bradycardia (beta-1 receptor blockade). Non-selective beta-blocker eye drops (such as timolol), frequently used to treat open-angle glaucoma, can drain through the nasolacrimal duct and be absorbed by the highly vascular nasal mucosa. Because this route bypasses first-pass hepatic metabolism, it can produce profound systemic effects. This scenario underscores the importance of rigorous medical history evaluation, as patients often do not consider eye drops to be 'medications' and may omit them unless asked direct, targeted questions.

Step-by-Step Solution

1
Analyze the patient's acute clinical presentation.
The patient is presenting with a severe asthma exacerbation (wheezing, hypoxia, tachypnea) accompanied by notable bradycardia (pulse 52/min), despite her asthma being well-controlled for over a decade.
Identifying the paired symptoms (bronchospasm + bradycardia) provides the physiologic signature of the offending agent.
2
Correlate the physical findings with the medical history.
The onset of symptoms closely follows the initiation of a new medication for elevated intraocular pressure (glaucoma), despite the patient initially omitting the eye drops from her medication list.
Patients frequently fail to report topical medications, inhalers, or supplements during standard medication reconciliation. Targeted history evaluation is required to uncover these agents.
3
Determine the pharmacologic class of the eye drop causing the specific adverse effects.
Ophthalmic non-selective beta-blockers (like timolol) are known to cause significant systemic beta-1 and beta-2 blockade due to absorption through the nasolacrimal mucosa.
Beta-2 antagonism causes the acute bronchospasm, and beta-1 antagonism causes the bradycardia, perfectly matching the clinical picture.

Key Concept

During medical history evaluation, targeted questioning about topical therapies (such as ophthalmic drops) is essential, as systemic absorption of agents like non-selective beta-blockers (e.g., timolol) via the nasolacrimal duct can precipitate life-threatening adverse effects such as bronchospasm and bradycardia.
Question 445Question →

Match each patient's clinical presentation of a suspected paraneoplastic syndrome with the most likely underlying neoplastic etiology and its associated pathophysiologic mechanism.

Click a left item, then click its matching right item

Items

A 65-year-old man with a significant smoking history presents with new-onset proximal muscle weakness that improves with repeated exercise, accompanied by absent deep tendon reflexes.
A 58-year-old woman with a palpable abdominal mass presents with recurrent episodes of facial flushing, frequent watery diarrhea, and a newly detected right-sided heart murmur.
A 70-year-old man with unintentional weight loss and vague abdominal pain develops recurrent, migratory superficial thrombophlebitis affecting multiple extremities.
A 50-year-old woman with a known adnexal mass presents with rapidly progressive cerebellar ataxia, dysarthria, and nystagmus over the past three weeks.

Matches

Show answer & explanation

Answer

Lambert-Eaton syndrome matches with small cell lung carcinoma (presynaptic calcium channel antibodies); Carcinoid syndrome matches with metastatic neuroendocrine tumor (serotonin/vasoactive peptides); Trousseau syndrome matches with pancreatic adenocarcinoma (mucins/tissue factor); Paraneoplastic cerebellar degeneration matches with ovarian/breast carcinoma (anti-Yo antibodies).
Paraneoplastic syndromes represent systemic manifestations of cancer that are not directly caused by the physical mass of the primary tumor or its metastases. Understanding these pathophysiologic connections is essential for early diagnosis and appropriate management. Lambert-Eaton is driven by presynaptic voltage-gated calcium channel antibodies (small cell lung cancer); carcinoid syndrome by serotonin and vasoactive peptides (metastatic neuroendocrine tumors); Trousseau syndrome by tumor-derived procoagulants (pancreatic adenocarcinoma); and paraneoplastic cerebellar degeneration by cross-reacting anti-Yo antibodies (ovarian/breast cancer).

Step-by-Step Solution

1
Evaluate the patient with proximal weakness improving with use and absent reflexes.
Identify Lambert-Eaton myasthenic syndrome.
This presentation points to a defect in presynaptic acetylcholine release due to calcium channel antibodies, typically triggered by small cell lung cancer.
2
Analyze the case of flushing, diarrhea, and right heart murmurs.
Identify carcinoid syndrome.
Systemic release of serotonin from a neuroendocrine tumor that has bypassed hepatic degradation causes these vasomotor and fibrotic symptoms.
3
Assess the presentation of migratory superficial thrombophlebitis.
Identify Trousseau syndrome.
This paraneoplastic hypercoagulability is heavily associated with pancreatic adenocarcinoma releasing mucins and tissue factor.
4
Review the acute cerebellar signs in a patient with an adnexal mass.
Identify paraneoplastic cerebellar degeneration.
The clinical picture strongly correlates with an ovarian malignancy driving an immune response via anti-Yo antibodies against Purkinje cells.

Key Concept

Paraneoplastic syndromes often provide early clinical clues to an underlying malignancy and are mediated by aberrant tumor secretion of hormones, peptides, or cross-reacting autoantibodies.
Question 446Question →

A 46-year-old man comes to the clinic for a follow-up visit regarding poorly controlled hypertension. Over the past 4 months, his blood pressure has consistently been in the 160s/100s mmHg despite adherence to maximum doses of amlodipine and lisinopril. He reports new-onset generalized muscle weakness, fatigue, and frequent urination. His medical history is significant for chronic dyspepsia, for which he recently began consuming large quantities of a European herbal black candy. He does not use tobacco or illicit drugs. Blood pressure is 168/98168/98 mmHg, and pulse is 78/min. Physical examination reveals no edema, normal secondary sexual characteristics, and no striae or easy bruising.

Laboratory studies show:
Serum sodium: 146 mEq/L
Serum potassium: 2.5 mEq/L
Serum chloride: 101 mEq/L
Serum bicarbonate: 32 mEq/L
Plasma renin activity: 0.1 ng/mL/hr (normal: 0.6-4.3 ng/mL/hr)
Plasma aldosterone: 1.2 ng/dL (normal: 3.0-30.0 ng/dL)
Morning serum cortisol: 16 μ\mu g/dL (normal: 5-23 μ\mu g/dL)

Which of the following best describes the specific molecular mechanism responsible for this patient's clinical and laboratory presentation?

Show answer & explanation

Answer: Inhibition of the intracellular conversion of cortisol to its inactive metabolite in the distal nephron

Answer

Inhibition of the intracellular conversion of cortisol to its inactive metabolite in the distal nephron
The correct answer describes the molecular mechanism of acquired apparent mineralocorticoid excess (AME) secondary to licorice ingestion. The patient's presentation of severe hypertension, hypokalemia, and metabolic alkalosis strongly suggests a state of mineralocorticoid excess. However, both plasma renin activity and aldosterone levels are markedly suppressed, eliminating primary and secondary hyperaldosteronism. The crucial historical clue is the patient's consumption of a 'European herbal black candy' for dyspepsia, which points to authentic black licorice. Black licorice contains glycyrrhizic acid, which is hydrolyzed in the gut to glycyrrhetinic acid. In the principal cells of the renal collecting duct, glycyrrhetinic acid competitively inhibits the enzyme 11 β\beta-hydroxysteroid dehydrogenase type 2 (11 β\beta-HSD2). Normally, 11 β\beta-HSD2 rapidly converts cortisol into its inactive metabolite, cortisone. This protects the mineralocorticoid receptor (MR) from cortisol, which circulates at concentrations 100 to 1,000 times higher than aldosterone but has equal affinity for the MR. When 11 β\beta-HSD2 is inhibited, local intracellular cortisol levels rise and inappropriately activate the MR, leading to enhanced sodium reabsorption, potassium excretion, and volume expansion with subsequent suppression of the renin-angiotensin-aldosterone system.

Step-by-Step Solution

1
Identify the primary clinical syndrome.
The patient has severe, treatment-resistant hypertension, profound hypokalemia, and metabolic alkalosis, indicating a state of mineralocorticoid excess.
Recognizing the triad of hypertension, hypokalemia, and alkalosis is the first step in localizing the pathology to the adrenal-renal axis.
2
Evaluate the renin-angiotensin-aldosterone system (RAAS) profile.
Both plasma renin activity and plasma aldosterone are markedly suppressed.
This rules out primary hyperaldosteronism (Conn syndrome - high aldosterone, low renin) and secondary hyperaldosteronism (high renin, high aldosterone).
3
Formulate a differential diagnosis for low-renin, low-aldosterone hypertension.
The differential includes exogenous mineralocorticoid use, Liddle syndrome, congenital adrenal hyperplasia (11 β\beta- or 17 α\alpha-hydroxylase deficiency), Cushing syndrome, and apparent mineralocorticoid excess (AME).
A structured differential prevents premature closure on genetic causes and forces consideration of acquired etiologies.
4
Correlate the medical history with the differential diagnosis.
The recent consumption of 'European herbal black candy' for dyspepsia suggests ingestion of authentic black licorice, which contains glycyrrhizic acid.
Identifying the trigger differentiates an acquired condition from congenital or genetic causes like Liddle syndrome or CAH.
5
Determine the precise molecular mechanism of the offending agent.
Glycyrrhetinic acid (the active metabolite of licorice) competitively inhibits 11 β\beta-hydroxysteroid dehydrogenase type 2 (11 β\beta-HSD2) in the renal collecting duct, preventing the conversion of cortisol to inactive cortisone and allowing cortisol to inappropriately activate the mineralocorticoid receptor.
This establishes the final mechanistic link required to answer the question correctly.

Key Concept

Licorice-induced apparent mineralocorticoid excess (AME) is caused by the inhibition of 11 β\beta-hydroxysteroid dehydrogenase type 2 (11 β\beta-HSD2) in the renal collecting duct, leading to inappropriate activation of the mineralocorticoid receptor by circulating cortisol.
Estimated Time:1m 30s
Question 447Question →

A 2929-year-old woman is evaluated in the clinic during a routine health maintenance examination. She has no symptoms of fatigue, abdominal pain, bone pain, or changes in urination. Her past medical history is unremarkable, and she takes no medications. Family history is significant for a maternal aunt who underwent neck surgery for an unspecified "calcium problem" in her 3030 s, though the patient states her aunt continues to have abnormal laboratory tests following the procedure. Vital signs are normal. Physical examination reveals a well-appearing patient with a normal thyroid gland and no palpable neck masses.

Laboratory evaluation shows:

TestResultReference Range
Serum calcium11.211.2 mg/dL8.48.4–10.210.2 mg/dL
Serum phosphorus2.42.4 mg/dL2.52.5–4.54.5 mg/dL
Serum albumin4.04.0 g/dL3.53.5–5.05.0 g/dL
Serum creatinine0.80.8 mg/dL0.60.6–1.11.1 mg/dL
Intact parathyroid hormone6868 pg/mL1010–6565 pg/mL

Which of the following is the most appropriate next step in evaluation?

Show answer & explanation

Answer: 24-hour urine collection for calcium and creatinine

Answer

The most appropriate next step is a 24-hour urine collection for calcium and creatinine to calculate the calcium-to-creatinine clearance ratio.
The correct answer is 24-hour urine collection for calcium and creatinine. This patient demonstrates hypercalcemia with an inappropriately elevated intact parathyroid hormone (PTH) level, indicating PTH-dependent hypercalcemia. The two leading differential diagnoses are primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH). FHH is an autosomal dominant disorder caused by a mutation in the calcium-sensing receptor (CASR) gene in the parathyroid glands and kidneys, leading to a higher set-point for calcium homeostasis and increased renal calcium reabsorption. This patient's family history of an aunt who had neck surgery that failed to cure her 'calcium problem' is a classic presentation of unrecognized FHH, as parathyroidectomy is ineffective for this condition. The essential next step to biochemically differentiate PHPT from FHH is calculating the urine calcium-to-creatinine clearance ratio (UCCR) using a 24-hour urine collection. A UCCR less than 0.010.01 strongly suggests FHH, while a ratio greater than 0.020.02 suggests PHPT.

Step-by-Step Solution

1
Interpret the initial laboratory results.
The patient has elevated serum calcium (11.211.2 mg/dL) with an intact PTH (6868 pg/mL) that is inappropriately elevated, categorizing the condition as PTH-dependent hypercalcemia.
Distinguishing between PTH-dependent and PTH-independent mechanisms is the critical first step in the hypercalcemia diagnostic algorithm.
2
Formulate a differential diagnosis based on the laboratory findings and patient history.
The primary considerations are primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcemia (FHH).
Both conditions present with hypercalcemia and normal or elevated PTH levels. The family history of an aunt who had unsuccessful neck surgery strongly raises the suspicion for FHH.
3
Determine the most appropriate initial biochemical test to differentiate the remaining diagnoses.
A 24-hour urine collection for calcium and creatinine is ordered to calculate the urine calcium-to-creatinine clearance ratio (UCCR).
UCCR reliably distinguishes between FHH (ratio typically <0.01< 0.01) and PHPT (ratio typically >0.02> 0.02). This ensures the patient does not undergo an unnecessary parathyroidectomy.

Key Concept

Patients presenting with PTH-dependent hypercalcemia must undergo evaluation with a 24-hour urine calcium and creatinine collection to rule out familial hypocalciuric hypercalcemia before proceeding with localizing imaging or surgical referral.
Estimated Time:1m 15s
Question 448Question →

A 39-year-old male is evaluated in the outpatient clinic for a four-month history of progressive tingling and burning pain in both feet. The symptoms are worse at night and frequently disrupt his sleep. He rarely visits healthcare providers and brings no medical records. Vital signs are within normal limits. His body mass index is 22 kg/m². Neurologic examination demonstrates diminished pinprick and vibratory sensation in a stocking distribution bilaterally, with absent ankle stretch reflexes. Motor strength is preserved in all extremities. To prioritize the differential diagnosis and guide subsequent laboratory testing, which of the following elements of the patient's medical history are essential to elicit? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Strict adherence to a plant-based diet excluding all animal products; Quantity, frequency, and duration of chronic ethanol consumption

Answer

The essential historical elements to elicit are the patient's adherence to a strict vegan diet and their chronic ethanol consumption.
The correct options identify historical elements pointing to vitamin B12 deficiency and alcoholic neuropathy. A strict vegan diet without proper supplementation lacks vitamin B12, eventually leading to subacute combined degeneration or isolated peripheral neuropathy. Chronic ethanol abuse causes direct neurotoxicity and is frequently associated with nutritional deficiencies (e.g., thiamine), leading to a symmetric, length-dependent axonal polyneuropathy. Both etiologies perfectly match the patient's presentation of a chronic, distal, sensory-predominant polyneuropathy with absent ankle reflexes.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient has a 4-month history of burning pain, tingling, stocking-distribution sensory loss, and absent ankle reflexes with preserved motor strength.
To identify the clinical syndrome as a chronic, symmetric, length-dependent sensorimotor polyneuropathy.
2
Formulate a differential diagnosis for chronic distal polyneuropathy in a young adult.
Common causes in a young to middle-aged adult without a known medical history include undiagnosed diabetes mellitus, vitamin B12 deficiency, and chronic alcohol abuse.
To determine which targeted historical questions will yield the highest-value diagnostic information.
3
Evaluate the provided historical inquiries against the established differential diagnosis.
Inquiring about a strict vegan diet targets vitamin B12 deficiency, and inquiring about ethanol consumption targets alcoholic neuropathy. The other options describe historical elements for conditions (Guillain-Barré syndrome, statin-induced myopathy, peripheral artery disease) that do not fit this chronic sensory presentation.
To select the options that specifically guide the diagnostic workup for the correct clinical syndrome.

Key Concept

Medical history evaluation for chronic symmetric distal polyneuropathy must explicitly include screening for common nutritional deficiencies (e.g., Vitamin B12) and toxic exposures (e.g., alcohol).
Question 449Question →

A comprehensive medical history, including the use of over-the-counter (OTC) products and dietary supplements, is essential for identifying occult toxicities. Match each patient's clinical presentation, derived from their specific exposure history, with the most accurate underlying pathophysiologic etiology.

Click a left item, then click its matching right item

Items

A 50-year-old man presents with an acute flare of podagra, severe facial flushing, and generalized pruritus shortly after initiating a new OTC vitamin regimen for dyslipidemia.
A 28-year-old woman develops daily pulsatile headaches, transient visual obscurations, and bilateral papilledema after starting a daily high-dose unregulated oral supplement for cystic acne.
A 65-year-old man develops progressive sensory ataxia, lower extremity spasticity, and a sideroblastic anemia after years of excessively applying a specific OTC dental adhesive for poorly fitting dentures.
A 40-year-old woman presents with tachycardia, tremor, weight loss, and a suppressed TSH with low serum thyroglobulin levels after starting a 'natural' fat-burning supplement.

Matches

Show answer & explanation

Answer

The correct pairings match the dyslipidemia vitamin to Niacin-induced hyperuricemia, the acne supplement to Hypervitaminosis A, the dental adhesive to Zinc-induced copper deficiency, and the fat-burning supplement to Exogenous thyrotoxicosis.
Each patient's clinical syndrome is a direct consequence of an over-the-counter or dietary supplement exposure that can only be diagnosed through a meticulous medical history. Niacin causes flushing and hyperuricemia; excessive vitamin A causes idiopathic intracranial hypertension; zinc in dental adhesives induces severe copper deficiency; and bovine thyroid extracts in weight loss supplements cause exogenous thyrotoxicosis.

Step-by-Step Solution

1
Analyze the clinical presentation and supplement history for the 50-year-old man.
The patient has an acute gout flare and flushing after taking a vitamin for dyslipidemia.
Niacin (B3) treats dyslipidemia but classically causes prostaglandin-induced flushing and hyperuricemia by competing for renal excretion.
2
Analyze the clinical presentation and supplement history for the 28-year-old woman.
The patient has signs of increased intracranial pressure (headaches, papilledema) after taking a supplement for acne.
Vitamin A and its derivatives are used for acne; hypervitaminosis A is a classic cause of idiopathic intracranial hypertension.
3
Analyze the clinical presentation and supplement history for the 65-year-old man.
The patient has myeloneuropathy and sideroblastic anemia linked to dental adhesive use.
Excessive use of zinc-containing dental adhesives causes zinc overload, which induces copper deficiency, mimicking vitamin B12 deficiency.
4
Analyze the clinical presentation and supplement history for the 40-year-old woman.
The patient has thyrotoxicosis with low thyroglobulin after taking a fat-burning supplement.
Low thyroglobulin indicates an exogenous source of thyroid hormone, commonly found in 'natural' supplements containing animal thyroid extracts.

Key Concept

Evaluating occult over-the-counter medications, vitamins, and dietary supplements as the primary etiology for complex clinical presentations.
Question 450Question →

A 22-year-old man presents to the gastroenterology clinic for evaluation of intermittent bright red blood per rectum over the past two months. He reports no abdominal pain, unexplained weight loss, or changes in stool caliber. His father died of metastatic colorectal cancer at age 38, and a paternal aunt underwent abdominal surgery for an unknown malignancy in her 30s. His temperature is 37.0°C (98.6°F), blood pressure is 118/76 mmHg, pulse is 72/min, and respirations are 14/min. Physical examination reveals a soft, non-tender abdomen without organomegaly. Digital rectal examination demonstrates normal sphincter tone with small amounts of bright red blood on the examining finger. Given his striking family history, a colonoscopy is performed and reveals over 150 small adenomatous polyps carpeting the entire colon and rectum. Biopsies of several polyps confirm tubular adenomas with low-grade dysplasia. Which of the following best describes the underlying foundational mechanism of this patient's condition and the most appropriate definitive management?

Show answer & explanation

Answer: Loss-of-function mutation in a gene regulating degradation of beta-catenin; prophylactic proctocolectomy

Answer

The correct option identifies a loss-of-function mutation in a gene regulating degradation of beta-catenin, managed definitively with a prophylactic proctocolectomy.
The correct answer accurately identifies both the molecular pathogenesis of Familial Adenomatous Polyposis (FAP) and its standard definitive management. FAP is caused by a germline loss-of-function mutation in the APC (Adenomatous Polyposis Coli) gene. The APC protein is a critical component of the Wnt signaling pathway, where it normally binds to beta-catenin and marks it for ubiquitination and proteasomal degradation. Without a functional APC protein, beta-catenin accumulates in the cytoplasm, translocates to the nucleus, and continuously activates transcription factors (like TCF/LEF) that promote cellular proliferation. Because patients with FAP develop hundreds to thousands of adenomatous polyps, they carry a nearly 100% lifetime risk of colorectal cancer. Therefore, once widespread polyposis is identified, prophylactic proctocolectomy (often with an ileoanal pouch anastomosis) is indicated to prevent malignant transformation.

Step-by-Step Solution

1
Analyze the clinical presentation and endoscopic findings.
A 22-year-old with a strong early-onset family history and >150 colonic polyps is highly indicative of Familial Adenomatous Polyposis (FAP).
Recognizing the classic phenotype of FAP distinguishes it from other hereditary cancer syndromes like Lynch syndrome, which presents with far fewer polyps.
2
Identify the foundational molecular mechanism of the disease.
FAP is an autosomal dominant condition caused by a germline mutation in the APC tumor suppressor gene.
The normal APC protein complexes with beta-catenin and targets it for degradation. Loss of APC allows beta-catenin to accumulate, enter the nucleus, and drive cellular proliferation.
3
Determine the appropriate long-term definitive management.
Prophylactic proctocolectomy.
Patients with FAP have a nearly 100% lifetime risk of developing colorectal carcinoma, usually by age 40 to 50, making surgical removal of the colon and rectum the standard of care once polyposis is established.

Key Concept

The molecular pathogenesis and clinical management of Familial Adenomatous Polyposis (FAP).
Question 451Question →

A hospital laboratory is reviewing several distinct metabolic profiles of patients with disorders of calcium homeostasis. Match each patient's serum and urine biochemical profile to the most likely underlying pathophysiological mechanism.

Click a left item, then click its matching right item

Items

Elevated serum Ca2+Ca^{2+}, decreased serum PO43−PO_4^{3-}, elevated intact PTH, and elevated 24-hour urinary calcium
Decreased serum Ca2+Ca^{2+}, elevated serum PO43−PO_4^{3-}, elevated intact PTH, and decreased 1,25-dihydroxycholecalciferol
Elevated serum Ca2+Ca^{2+}, high-normal intact PTH, and decreased fractional excretion of calcium (< 1%)
Elevated serum Ca2+Ca^{2+}, high-normal serum PO43−PO_4^{3-}, suppressed intact PTH, and elevated 1,25-dihydroxycholecalciferol
Decreased serum Ca2+Ca^{2+}, elevated serum PO43−PO_4^{3-}, suppressed intact PTH, and decreased 1,25-dihydroxycholecalciferol

Matches

Show answer & explanation

Answer

Profile 1 matches autonomous adenoma; Profile 2 matches impaired renal clearance; Profile 3 matches CaSR mutation; Profile 4 matches ectopic macrophage activity; Profile 5 matches absent parathyroid tissue.
Each laboratory profile uniquely matches a specific pathophysiological lesion. The interplay between calcium, phosphorus, PTH, and vitamin D allows for precise localization of the defect to the parathyroid glands, kidneys, calcium-sensing receptors, or ectopic sources.

Step-by-Step Solution

1
Analyze the parathyroid hormone (PTH) levels relative to the serum calcium levels.
In profiles 1, 3, and 4, hypercalcemia is present. In profiles 2 and 5, hypocalcemia is present.
Determining whether PTH is appropriately suppressed or inappropriately elevated helps distinguish parathyroid-dependent from parathyroid-independent mechanisms.
2
Evaluate hypercalcemic profiles (1, 3, 4).
Profile 1 has high PTH and high urine calcium (Primary hyperparathyroidism). Profile 3 has normal/high PTH and low urine calcium (FHH). Profile 4 has suppressed PTH and high active vitamin D (Granulomatous disease).
Urinary calcium and vitamin D levels differentiate the underlying causes of hypercalcemia.
3
Evaluate hypocalcemic profiles (2, 5).
Profile 2 has elevated PTH (Secondary hyperparathyroidism due to CKD). Profile 5 has suppressed PTH (Primary hypoparathyroidism).
The PTH response defines whether the defect is in the parathyroid glands themselves or due to chronic end-organ dysfunction.

Key Concept

Differential diagnosis of calcium and phosphate homeostasis disorders based on the parathyroid hormone, 1,25-dihydroxyvitamin D, and urinary calcium axes.
Question 452Question →

A 30-year-old healthcare worker is undergoing routine employee health screening. As part of a clinic educational review, various patient Hepatitis B serologic panels are evaluated. Match each of the following Hepatitis B laboratory serologic patterns to the most accurate diagnostic interpretation.

Click a left item, then click its matching right item

Items

HBsAg (+), Anti-HBc IgM (+), Anti-HBs (-)
HBsAg (-), Anti-HBc IgG (+), Anti-HBs (+)
HBsAg (-), Anti-HBc (-), Anti-HBs (+)
HBsAg (+), Anti-HBc IgG (+), Anti-HBs (-)

Matches

Show answer & explanation

Answer

Pattern 1 matches Acute infection; Pattern 2 matches Resolved infection; Pattern 3 matches Vaccination immunity; Pattern 4 matches Chronic infection.
Each laboratory pattern uniquely identifies a distinct phase of Hepatitis B infection or immunity. Active infection is defined by the presence of HBsAg, which is further classified as acute (IgM Anti-HBc) or chronic (IgG Anti-HBc). Immunity is defined by the presence of Anti-HBs. Natural immunity features Anti-HBc IgG due to exposure to the whole virus, whereas vaccine-induced immunity lacks Anti-HBc entirely.

Step-by-Step Solution

1
Analyze the HBsAg status for each serologic pattern.
Patterns 1 and 4 are HBsAg positive, indicating active viral infection. Patterns 2 and 3 are HBsAg negative, indicating no active infection and potential immunity.
HBsAg (surface antigen) is the primary marker of active viral presence, whether acute or chronic.
2
Evaluate the Anti-HBc (core antibody) and Anti-HBs (surface antibody) status to finalize the interpretation.
Pattern 1 has IgM Anti-HBc (acute). Pattern 4 has IgG Anti-HBc (chronic). Pattern 2 has IgG Anti-HBc plus Anti-HBs (resolved natural infection). Pattern 3 has Anti-HBs but lacks Anti-HBc entirely (vaccination).
Core antibodies develop only after natural exposure to the complete virus. Recombinant vaccines only contain the surface antigen, producing isolated Anti-HBs.

Key Concept

Hepatitis B Serology Interpretation
Estimated Time:1m 0s
Question 453Question →

An established patient in the primary care clinic, a 47-year-old male, is evaluated during a follow-up visit for difficult-to-control blood pressure. He reports taking his prescribed regimen of maximum-dose lisinopril, amlodipine, and chlorthalidone consistently. He occasionally experiences mild muscle cramps in his calves but otherwise feels well. Blood pressure is 164/96 mmHg and heart rate is 76/min. Physical examination is unremarkable with no abdominal bruits, edema, or focal neurological deficits. A basic metabolic panel reveals a serum sodium of 144 mEq/L, a serum potassium of 3.1 mEq/L, and a serum creatinine of 0.9 mg/dL. Which of the following is the most appropriate next step in the laboratory evaluation of this patient?

Show answer & explanation

Answer: Measurement of morning plasma aldosterone concentration and plasma renin activity

Answer

Measurement of morning plasma aldosterone concentration and plasma renin activity
The correct sequence for diagnosing primary aldosteronism begins with biochemical screening. The patient presents with resistant hypertension (blood pressure above target despite concurrent use of three antihypertensive agents of different classes, one of which is a thiazide-like diuretic) and hypokalemia. This triad is highly suspicious for primary aldosteronism (Conn syndrome). The most appropriate initial laboratory evaluation is measuring the morning plasma aldosterone concentration (PAC) and plasma renin activity (PRA). A PAC/PRA ratio greater than 20 with a PAC greater than 15 ng/dL strongly suggests the diagnosis and justifies moving to confirmatory testing.

Step-by-Step Solution

1
Identify the clinical syndrome
The patient has resistant hypertension (uncontrolled on three antihypertensive agents of different classes, including a diuretic) accompanied by hypokalemia.
Recognizing resistant hypertension with hypokalemia is the classic trigger for suspecting primary aldosteronism.
2
Determine the appropriate diagnostic sequence
The initial step is a biochemical screening test, rather than a confirmatory test or anatomic imaging.
Endocrine diagnostic algorithms require sensitive screening tests before performing invasive or cumbersome confirmatory testing.
3
Select the specific laboratory test
A paired morning plasma aldosterone concentration (PAC) and plasma renin activity (PRA) is ordered to calculate the PAC/PRA ratio.
This is the gold-standard initial screening test for primary aldosteronism.

Key Concept

Patients presenting with resistant hypertension and hypokalemia (whether spontaneous or diuretic-induced) should be screened for primary aldosteronism using the plasma aldosterone concentration to plasma renin activity ratio.
Question 454Question →

A 28-year-old woman is admitted to the medical ward with a 3-day history of high fever, marked facial swelling, and a widespread skin eruption. She reports that the rash began on her face and upper trunk before spreading to her extremities. Four weeks ago, she was prescribed sulfasalazine for newly diagnosed inflammatory bowel disease. Her temperature is 39.2°C (102.6°F), blood pressure is 110/70 mmHg, and pulse is 112/min. Physical examination reveals prominent periorbital edema, generalized cervical lymphadenopathy, and a diffuse, confluent, erythematous maculopapular rash covering 70% of her body surface area. There is no mucosal ulceration or epidermal detachment. Laboratory studies show:

Leukocyte count: 18,500/mm318,500/\text{mm}^3
Eosinophils: 2,500/mm32,500/\text{mm}^3 (normal: 15–500/mm315–500/\text{mm}^3)
Alanine aminotransferase (ALT): 450 U/L
Aspartate aminotransferase (AST): 410 U/L
Serum creatinine: 1.1 mg/dL

Which of the following best describes the predominant immunopathologic mechanism driving this patient's clinical syndrome?

Show answer & explanation

Answer: Oligoclonal expansion of T-lymphocytes with subsequent release of interleukin-5

Answer

The correct mechanism is the oligoclonal expansion of T-lymphocytes with subsequent release of interleukin-5, which characterizes DRESS syndrome.
The patient's presentation (a latency period of 4 weeks, prominent facial edema, fever, generalized rash, lymphadenopathy, profound eosinophilia, and hepatic injury) is the classic triad for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome. Sulfasalazine, alongside anticonvulsants and allopurinol, is a notorious trigger. DRESS is classified as a severe, delayed-type (Type IVb) hypersensitivity reaction. The pathogenesis is driven by the oligoclonal expansion of drug-specific T-lymphocytes (predominantly Th2 cells). These T-cells secrete massive amounts of interleukin-5 (IL-5), a cytokine that specifically stimulates eosinophil production, activation, and subsequent infiltration into tissues such as the liver, skin, and heart, resulting in severe end-organ damage.

Step-by-Step Solution

1
Analyze the timeline and clinical presentation.
The patient developed high fever, facial edema, diffuse rash, and lymphadenopathy exactly 4 weeks after starting sulfasalazine.
This specific 2 to 8-week latency period combined with systemic signs and facial edema strongly suggests a delayed-type drug reaction rather than an acute allergy.
2
Evaluate the laboratory findings in the context of the physical exam.
Labs reveal profound peripheral eosinophilia (2,500/mm32,500/\text{mm}^3) and severe transaminitis (ALT 450 U/L), without mucosal ulceration or skin sloughing.
Visceral organ involvement (most commonly hepatic) combined with significant eosinophilia confirms the diagnosis of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, differentiating it from Stevens-Johnson syndrome (SJS).
3
Identify the underlying immunopathologic mechanism.
DRESS is a Type IVb hypersensitivity reaction.
It is mediated by drug-specific T-cells (primarily Th2 phenotype) that secrete large amounts of interleukin-5 (IL-5), driving the proliferation, activation, and tissue infiltration of eosinophils that cause end-organ damage.

Key Concept

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome is a severe Type IVb hypersensitivity reaction mediated by T-cells that secrete IL-5, leading to eosinophilic tissue infiltration and organ damage.
Question 455Question →

A 3232-year-old man comes to the clinic to establish care. He feels well and has no medical problems. He takes no medications. Vital signs are within normal limits. Routine laboratory testing reveals a serum calcium level of 11.211.2 mg/dL (N: 8.48.4-10.210.2 mg/dL) and a serum intact parathyroid hormone level of 5555 pg/mL (N: 1515-6565 pg/mL). A 2424-hour urine collection shows a calcium excretion of 4545 mg/day (N: 100100-300300 mg/day). The urine calcium-to-creatinine clearance ratio is calculated to be 0.0050.005 (normal >0.02>0.02). His mother also has a history of mild, asymptomatic hypercalcemia that was treated with a parathyroidectomy in her 3030 s without resolution of the hypercalcemia. Which of the following best describes the cellular mechanism underlying this patient's laboratory findings?

Show answer & explanation

Answer: Decreased sensitivity of a G protein-coupled receptor to extracellular cations

Answer

Decreased sensitivity of a G protein-coupled receptor to extracellular cations
The correct answer accurately describes the pathophysiology of familial hypocalciuric hypercalcemia (FHH). FHH is an autosomal dominant disorder caused by an inactivating mutation in the calcium-sensing receptor (CaSR) gene. The CaSR is a G protein-coupled receptor located on the chief cells of the parathyroid gland and the basolateral membrane of the thick ascending limb of the loop of Henle. In FHH, the mutated CaSR requires higher concentrations of extracellular calcium to activate its intracellular Gq signaling cascade. This decreased sensitivity raises the set-point for calcium homeostasis, resulting in mild hypercalcemia with an inappropriately normal or slightly elevated PTH level. In the kidneys, the defective CaSR leads to increased calcium reabsorption, causing marked hypocalciuria and a characteristic urine calcium-to-creatinine clearance ratio of less than 0.01. Parathyroidectomy is generally ineffective and not indicated.

Step-by-Step Solution

1
Analyze the initial serum laboratory results.
The patient has hypercalcemia with an inappropriately normal intact PTH level.
Normal physiological feedback dictates that hypercalcemia should suppress PTH secretion. An unsuppressed PTH narrows the differential to PTH-dependent causes, primarily primary hyperparathyroidism and familial hypocalciuric hypercalcemia (FHH).
2
Evaluate the urine calcium indices and family history to differentiate the diagnosis.
The 24-hour urine calcium is low, the clearance ratio is less than 0.01, and there is a family history of failed parathyroidectomy.
Primary hyperparathyroidism typically presents with increased urinary calcium excretion and a clearance ratio >0.02. The combination of hypocalciuria, a low clearance ratio, and surgical failure in a first-degree relative strongly establishes the diagnosis of FHH.
3
Identify the underlying cellular mechanism of the diagnosed condition.
FHH is caused by an inactivating mutation of the calcium-sensing receptor (CaSR), which is a G protein-coupled receptor.
The mutated CaSR has decreased sensitivity to extracellular calcium, requiring higher serum calcium levels to suppress PTH secretion and leading to increased renal tubular calcium reabsorption.

Key Concept

Familial hypocalciuric hypercalcemia (FHH) is caused by an inactivating mutation of the calcium-sensing receptor (CaSR), a G protein-coupled receptor, leading to a higher set-point for calcium homeostasis.
Question 456Question →

A 64-year-old man with a history of chronic obstructive pulmonary disease and long-standing alcohol use disorder is evaluated in the emergency department for progressive abdominal swelling, shortness of breath, and bilateral leg swelling over the past month. Vital signs show a blood pressure of 110/70 mmHg, a heart rate of 95/min, and a respiratory rate of 20/min. Oxygen saturation is 91% on room air. Physical examination reveals elevated jugular venous pulsation 9 cm above the sternal angle. Chest auscultation demonstrates distant breath sounds and expiratory wheezing bilaterally. The abdomen is markedly distended with shifting dullness and a positive fluid wave. There is 3+ pitting edema of the lower extremities up to the knees. Diagnostic paracentesis is performed, and laboratory results are as follows:

Serum
Total protein: 6.5 g/dL
Albumin: 3.4 g/dL
Total bilirubin: 1.8 mg/dL
Sodium: 135 mEq/L

Ascitic fluid
Color: Straw-colored, clear
Total protein: 3.1 g/dL
Albumin: 1.8 g/dL
White blood cell count: 210/mm³
Neutrophils: 15%
Lymphocytes: 45%

Based on the clinical presentation and laboratory findings, which of the following is the most likely underlying cause of this patient's ascites?

Show answer & explanation

Answer: Right ventricular failure

Answer

Right ventricular failure
The correct answer synthesizes three key pieces of data: the serum-ascites albumin gradient (SAAG), the ascitic total protein, and the clinical signs. The SAAG is calculated as serum albumin (3.4 g/dL3.4 \text{ g/dL}) minus ascitic albumin (1.8 g/dL1.8 \text{ g/dL}), yielding 1.6 g/dL1.6 \text{ g/dL}. A SAAG ≥1.1 g/dL\geq 1.1 \text{ g/dL} is diagnostic of portal hypertension. Next, evaluating the ascitic total protein helps isolate the location of the portal hypertension. An ascitic total protein ≥2.5 g/dL\geq 2.5 \text{ g/dL} indicates a post-sinusoidal cause, such as cardiac ascites (due to heart failure) or early Budd-Chiari syndrome, because the hepatic sinusoids remain permeable and allow protein to leak into the ascitic fluid. This laboratory pattern, combined with the patient's elevated jugular venous pulsation and history of chronic obstructive pulmonary disease, confirms right ventricular failure (cor pulmonale) as the primary etiology.

Step-by-Step Solution

1
Calculate the serum-ascites albumin gradient (SAAG).
SAAG = Serum Albumin (3.4 g/dL) - Ascitic Albumin (1.8 g/dL) = 1.6 g/dL.
The SAAG determines whether ascites is caused by portal hypertension (SAAG ≥1.1 g/dL\geq 1.1 \text{ g/dL}) or another non-portal mechanism (SAAG <1.1 g/dL< 1.1 \text{ g/dL}).
2
Evaluate the ascitic total protein concentration.
Ascitic total protein is 3.1 g/dL3.1 \text{ g/dL} (≥2.5 g/dL\geq 2.5 \text{ g/dL}).
In portal hypertension, a high ascitic protein level indicates structurally preserved but congested hepatic sinusoids (post-sinusoidal etiology, like cardiac ascites), whereas a low level (<2.5 g/dL< 2.5 \text{ g/dL}) indicates fibrosed sinusoids (like cirrhosis).
3
Calculate the absolute neutrophil count (ANC) in the ascitic fluid.
ANC = 210×0.15=31.5/mm3210 \times 0.15 = 31.5/\text{mm}^3.
An ANC ≥250/mm3\geq 250/\text{mm}^3 is required to diagnose spontaneous bacterial peritonitis. The low ANC rules out this infection.
4
Synthesize laboratory data with clinical findings.
The lab pattern confirms cardiac ascites, aligning with the elevated jugular venous pulsation and chronic obstructive pulmonary disease history.
The patient has right ventricular failure (cor pulmonale) secondary to COPD, causing post-sinusoidal portal hypertension.

Key Concept

The diagnostic evaluation of ascites requires calculating the SAAG to identify portal hypertension (≥1.1 g/dL\geq 1.1 \text{ g/dL}) and utilizing ascitic total protein to differentiate sinusoidal (cirrhotic, <2.5 g/dL< 2.5 \text{ g/dL}) from post-sinusoidal (cardiac, ≥2.5 g/dL\geq 2.5 \text{ g/dL}) etiologies.
Estimated Time:1m 30s
Question 457Question →

Match each patient's clinical presentation with the precise immunopathologic mechanism responsible for their condition.

Click a left item, then click its matching right item

Items

A 23-year-old man presents with his second episode of systemic meningococcal infection despite appropriate prior antibiotic therapy.
A 35-year-old woman develops non-pitting, non-pruritic facial edema and severe colicky abdominal pain without urticaria, unresponsive to antihistamines.
A 19-year-old woman presents with a photosensitive malar rash, severe arthralgias, and proteinuria; laboratory testing reveals an undetectable CH50.
A 42-year-old man is admitted with chronic fatigue, episodic morning hematuria, and a newly diagnosed acute portal vein thrombosis.

Matches

Show answer & explanation

Answer

The first clinical vignette matches with deficient C5b-9 formation. The second matches with unregulated kallikrein activation. The third matches with defective opsonization of immune complexes. The fourth matches with absence of GPI-anchored inhibitors.
Each vignette represents a classic presentation of a complement-related immunological defect. The terminal pathway is uniquely required to fight Neisseria. The contact system's dysregulation via C1-INH deficiency causes bradykinin-mediated angioedema. The classical pathway is necessary to clear immune complexes, preventing autoimmunity. Finally, PNH is a disorder of absent complement-regulating surface proteins, leading to complement-mediated intravascular hemolysis and thrombosis.

Step-by-Step Solution

1
Identify the underlying disease for each clinical vignette.
Patient 1 has a terminal complement deficiency. Patient 2 has hereditary angioedema. Patient 3 has early complement deficiency-associated SLE. Patient 4 has paroxysmal nocturnal hemoglobinuria.
Accurate clinical diagnosis is required to link the presentation to the underlying foundational science mechanism.
2
Map each identified disease to its specific immunopathologic mechanism.
Terminal complement deficiency limits MAC (C5b-9) formation. Hereditary angioedema involves C1 inhibitor defect leading to excess bradykinin. Early complement deficiency prevents immune complex clearance. PNH lacks CD55/CD59 GPI anchors.
This establishes the foundational pathophysiology connecting clinical syndromes to immunologic processes.

Key Concept

Immunopathogenesis of complement system defects and regulatory protein deficiencies
Question 458Question →

A 44-year-old man presents to the oncology clinic for treatment planning of newly diagnosed metastatic colorectal cancer. He initially presented to his primary care physician with fatigue and was found to have iron deficiency anemia. A subsequent colonoscopy revealed a 3.5-cm ulcerated mass in the ascending colon, and a computed tomography scan of the abdomen and pelvis showed multiple hepatic metastases. His family history is notable for his father dying of colon cancer at age 48 and a paternal aunt who was treated for endometrial cancer at age 46.

Physical examination reveals pale conjunctivae and a palpable liver edge 3 cm below the right costal margin. Laboratory studies show a hemoglobin of 9.2 g/dL.

Biopsy of the hepatic lesion confirms metastatic adenocarcinoma. Immunohistochemical staining of the biopsy specimen demonstrates intact expression of MLH1 and PMS2 proteins, but absent expression of MSH2 and MSH6 proteins. The oncologist recommends initiating therapy with a programmed cell death protein 1 (PD-1) inhibitor.

Which of the following molecular characteristics best explains why this patient's neoplasm is highly susceptible to this specific pharmacologic therapy?

Show answer & explanation

Answer: Accumulation of frameshift mutations resulting in the robust generation of immunogenic neoantigens

Answer

Accumulation of frameshift mutations resulting in the robust generation of immunogenic neoantigens
The correct answer correctly identifies the molecular downstream effect of defective DNA mismatch repair (dMMR). In this patient with Lynch syndrome, the loss of MSH2 and MSH6 leads to a failure to correct DNA replication errors. This causes microsatellite instability (MSI), where repetitive DNA sequences accumulate frameshift mutations. These mutations translate into novel, abnormal peptide sequences known as neoantigens. The presence of numerous neoantigens makes the tumor highly visible (immunogenic) to the patient's cytotoxic T-cells. To survive, these tumors typically upregulate immune checkpoint proteins like PD-L1 to suppress the T-cell response. Administering a PD-1 inhibitor blocks this interaction, unleashing a potent, pre-existing immune response against the neoantigen-rich tumor.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and family history.
Early-onset right-sided colon cancer with a family history of colon and endometrial cancers strongly suggests Lynch syndrome.
Identifying the clinical syndrome provides the context for interpreting the molecular testing.
2
Interpret the tumor immunohistochemistry (IHC) results.
The absence of MSH2 and MSH6 proteins indicates defective DNA mismatch repair (dMMR).
IHC is the standard test to determine the functional status of mismatch repair proteins in colorectal cancer.
3
Correlate dMMR with its downstream molecular consequences.
Defective mismatch repair leads to microsatellite instability (MSI), causing numerous frameshift mutations and the production of novel, altered proteins (neoantigens).
Understanding the pathogenesis explains why these specific tumors interact differently with the immune system.
4
Determine the therapeutic rationale for using a PD-1 inhibitor.
The high burden of neoantigens makes the tumor highly immunogenic. The tumor survives by upregulating PD-L1 to exhaust T-cells; a PD-1 inhibitor blocks this evasion, allowing T-cells to attack the tumor.
Connects the underlying cellular pathology directly to the clinical management choice.

Key Concept

Tumors with mismatch repair deficiency (dMMR), such as those seen in Lynch syndrome, develop high microsatellite instability and a massive burden of frameshift-derived neoantigens. This high immunogenicity makes them exceptionally responsive to immune checkpoint inhibitors like PD-1 antibodies.
Estimated Time:1m 30s
Question 459Question →

A 32-year-old woman with severe symptomatic iron deficiency anemia is admitted to the hospital and started on a transfusion of packed red blood cells. Fifteen minutes after the transfusion is initiated, she acutely develops chills, severe lower back pain, and a feeling of impending doom. Her temperature is 39.1°C (102.4°F), blood pressure is 88/54 mm Hg, heart rate is 124/min, and respiratory rate is 24/min. Physical examination reveals flushing and diaphoresis. An acute hemolytic transfusion reaction is suspected. Arrange the following steps in the most appropriate chronological sequence for the immediate management and diagnostic workup of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first discontinue the transfusion, then maintain intravenous access with normal saline using new tubing, followed by a bedside clerical check, sending appropriate samples to the blood bank, and finally administering vasopressors if hypotension persists.
In an acute hemolytic transfusion reaction (AHTR), preformed host antibodies bind to donor red blood cells, causing robust complement activation and intravascular hemolysis. The immediate priority is to stop the offending immunologic trigger by discontinuing the transfusion. To prevent hypotension and acute kidney injury from free hemoglobin, intravenous fluids (0.9% normal saline) must be started immediately. Crucially, the old tubing must be disconnected and replaced so that residual incompatible blood is not flushed into the patient. Once stabilized, the physician must perform a bedside clerical check, as misidentification is the most common cause of AHTR. Subsequently, the blood bank is notified, and post-reaction samples (blood and urine) are sent to assess for hemolysis and perform a direct antiglobulin test (DAT). Finally, if the patient remains hypotensive despite initial fluid boluses, vasoactive medications (vasopressors) are administered as advanced supportive care.

Step-by-Step Solution

1
Recognize the clinical presentation as an acute hemolytic transfusion reaction (AHTR).
Identify that the patient's acute-onset fever, flank pain, and hypotension shortly after starting a transfusion indicate a life-threatening Type II hypersensitivity reaction.
AHTR is driven by preformed host antibodies (usually anti-A or anti-B) attacking donor red blood cells, triggering massive complement activation, intravascular hemolysis, and systemic cytokine release.
2
Prioritize immediate interventions to halt the immunologic trigger and stabilize hemodynamics.
Determine that stopping the transfusion and replacing the intravenous tubing to infuse normal saline are the absolute critical first steps.
Limiting antigen exposure is the most important intervention to halt the hypersensitivity cascade. Using new tubing prevents inadvertently flushing residual incompatible blood into the patient.
3
Sequence the subsequent diagnostic and supportive management steps.
Place the bedside clerical check before laboratory notification and sample collection, with advanced supportive care (vasopressors) reserved for refractory instability.
A clerical error is the most common cause of AHTR and must be checked immediately. Laboratory tests confirm the diagnosis, and pressors are a secondary intervention for fluid-refractory shock.

Key Concept

The management of an acute hemolytic transfusion reaction (a Type II hypersensitivity response) prioritizes immediately halting the transfusion, maintaining hemodynamic stability with normal saline via new tubing, and aggressively investigating the cause, starting with a bedside clerical check.
Question 460Question →

During a routine outpatient clinic visit, a 5858-year-old male patient reports a 22-month history of progressive, deep, aching pain in his shins and wrists. He also describes worsening generalized fatigue and a 4-kg4\text{-kg} (9-lb9\text{-lb}) weight loss over the same period. He has a 30-pack-year30\text{-pack-year} smoking history and has not seen a physician in over a decade. Vital signs, including oxygen saturation on room air, are within normal limits. On physical examination, there is pronounced clubbing of the fingers and toes. There is bilateral, symmetrical, warm swelling of the wrists, metacarpophalangeal joints, and ankles. Deep palpation over the distal tibia and distal radius elicits exquisite periosteal tenderness. Cardiac auscultation reveals a regular rhythm with no murmurs, rubs, or gallops. Pulmonary examination demonstrates slightly decreased breath sounds at the right lung apex but is otherwise clear. Routine laboratory studies show a mild normocytic anemia and a borderline elevated rheumatoid factor of 24 IU/mL24\text{ IU/mL} (normal <20 IU/mL<20\text{ IU/mL}). Based on this patient's specific constellation of physical examination findings, which of the following is the most appropriate next step in establishing the underlying diagnosis?

Show answer & explanation

Answer: Chest radiography

Answer

Chest radiography
The correct answer is chest radiography. This patient presents with the classic physical examination triad of hypertrophic osteoarthropathy (HOA): digital clubbing, sudden-onset arthropathy, and exquisite periosteal tenderness of the long bones (periostosis). In an adult with a significant smoking history and constitutional symptoms, HOA is most commonly a paraneoplastic syndrome secondary to an underlying intrathoracic malignancy, particularly non-small cell lung cancer (e.g., adenocarcinoma). The pathogenesis involves megakaryocytes bypassing pulmonary capillary fragmentation, entering the systemic circulation, and releasing vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) in the distal extremities. Because of this strong association, the most appropriate initial diagnostic step to establish the underlying etiology is a chest radiograph to evaluate for a lung mass.

Step-by-Step Solution

1
Analyze the constellation of physical examination findings.
The patient exhibits digital clubbing, symmetrical polyarthritis, and exquisite periosteal tenderness over the distal long bones.
Identifying the specific pattern of clinical signs is crucial for formulating an accurate differential diagnosis rather than addressing each symptom in isolation.
2
Synthesize the findings into a unifying clinical syndrome.
The triad of clubbing, arthritis, and periostitis constitutes hypertrophic osteoarthropathy (HOA).
HOA is a distinct clinical entity whose etiology differs significantly from primary rheumatologic joint diseases.
3
Correlate the clinical syndrome with the patient's demographics and risk factors.
In a 5858-year-old patient with a heavy smoking history and constitutional symptoms (weight loss, fatigue), HOA is highly suggestive of a paraneoplastic process.
Secondary HOA is most frequently associated with underlying intrathoracic malignancies, particularly non-small cell lung cancer (e.g., adenocarcinoma).
4
Determine the most appropriate initial diagnostic study.
A chest radiograph is the most appropriate next step to evaluate for a primary lung neoplasm.
Identifying and treating the underlying malignancy is the primary goal in the management of secondary HOA.

Key Concept

Hypertrophic osteoarthropathy (HOA) presents with digital clubbing, polyarthritis, and periostosis (periosteal tenderness). In adults with smoking histories, it is strongly associated with intrathoracic malignancies and necessitates initial imaging of the chest.
Estimated Time:1m 30s
PreviousPage 23 / 237Next
All practice questions — USMLE Step 3 | Examkin